Is MIRM or MNKD more undervalued in 2026?

CirclFi compares Mirum Pharmaceuticals, Inc. (MIRM) and MannKind Corporation (MNKD) using 13 institutional-grade valuation models. MIRM has a Quality of Company score of 7.1/10 while MNKD scores 7.0/10.

Which is a better buy — MIRM or MNKD?

Compare intrinsic values from 13 independent models against current market prices. CirclFi also calculates Value Trap scores. This is not financial advice — conduct your own analysis.

How do MIRM and MNKD valuations compare?

MIRM at $99.60 and MNKD at $3.64 are compared across Bayesian DCF, EPV, EROIC Spread, First Chicago, Markov DDM, and 8 additional models.

MIRM vs MNKD Valuation Comparison 2026 — Intrinsic Value Analysis

MIRM

Biotechnology

Mirum Pharmaceuticals, Inc.

Quality

7.1

out of 10

Value Trap

SAFE

Price

$99.60

Last close

Models

13/13

Active

MNKD

Biotechnology

MannKind Corporation

Quality

7.0

out of 10

Value Trap

SAFE

Price

$3.64

Last close

Models

12/13

Active

Model-by-Model Comparison

Model	Type	MIRM Fair Value	MIRM Upside	MNKD Fair Value	MNKD Upside
Bayesian DCF	Intrinsic	$15.18	-84.8%	$0.32	-90.6%
Earnings Power Value	Intrinsic	$48.67	-46.8%	$0.26	-92.9%
EROIC Spread	Intrinsic	$•••.••	••.•%	$•••.••	••.•%
First Chicago	Scenario	$•••.••	••.•%	$•••.••	••.•%
Markov DDM	Intrinsic	$•••.••	••.•%	$•••.••	••.•%
ML-RIV	Intrinsic	$•••.••	••.•%	$•••.••	••.•%
Dynamic NAV	Asset-Based	$•••.••	••.•%	$•••.••	••.•%
PWERM	Option-Based	$•••.••	••.•%	$•••.••	••.•%
Regime Cross-Sectional	Relative	$•••.••	••.•%	$•••.••	••.•%
Sentiment SOTP	Hybrid	$•••.••	••.•%	$•••.••	••.•%
CUCE Ensemble	Ensemble	$•••.••	••.•%	$•••.••	••.•%
FTNN Topology	Relative	$•••.••	••.•%	$•••.••	••.•%
RCMH-DCF	Intrinsic	$•••.••	••.•%	$•••.••	••.•%

🔒

Unlock Full 13-Model Comparison

Access all valuation models for MIRM vs MNKD — including EROIC Spread, First Chicago, Markov DDM, PWERM, and 7 more.

Access Full Analysis — From $27/mo →

MIRM vs MNKD — Which Stock Is More Undervalued?

MIRM scores higher with a 7.1/10 quality rating vs MNKD's 7.0/10. Both stocks are analyzed daily using SEC EDGAR filings across 13 independent models.

Comparing Mirum Pharmaceuticals, Inc. (MIRM) and MannKind Corporation (MNKD) across 13 institutional-grade valuation models reveals how each company's intrinsic value stacks up against its market price. CirclFi's engine processes SEC EDGAR 10-K and 10-Q filings, FRED macroeconomic data, and GDELT news sentiment to generate independent fair value estimates daily.

MIRM currently trades at $99.60 with a QOC of 7.1/10, while MNKD trades at $3.64 with a QOC of 7.0/10.

Both companies are analyzed with models spanning intrinsic (Bayesian DCF, EPV), scenario-based (First Chicago), regime-switching (Markov DDM, RCMH-DCF), machine learning (ML-RIV, FTNN Topology), and ensemble methods (CUCE).